A compound with the SMILES C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)Cn3cc(CC(C)O)nn3)CC2)nc(N2CCN(C(=O)Cn3cc(CC(C)O)nn3)CC2)n1 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 12.486\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)Cn3cc(CC(C)O)nn3)CC2)nc(N2CCN(C(=O)Cn3cc(CC(C)O)nn3)CC2)n1
C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)Cn3cc(CC(C)O)nn3)CC2)nc(N2CCN(C(=O)Cn3cc(CC(C)O)nn3)CC2)n1
2-[4-(2-hydroxypropyl)triazol-1-yl]-1-[4-[4-[4-[2-[4-(2-hydroxypropyl)triazol-1-yl]acetyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]ethanone